Study on Covid vaccines: “adequate patient comprehension of [ADE] risk is unlikely to occur, obviating truly informed consent by subjects in these trials.”

Everyone who gets the vaccine is a “subject of these trials.” ABN

Conclusions drawn from the study and clinical implications: The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.

Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease